Decrease (-) Restore Default Increase (+)

Oncology-Hematology

Program Director's Message

Our focus is to develop clinicians who are adept at prevention, screening, diagnosis and treatment of a broad range of malignancies, as well as benign hematologic disease. This is a three-year program of comprehensive clinical training in both medical oncology and hematology, satisfying double-board eligibility, with protected time to pursue an original research project. Fellows are trained in all procedures relating to oncology/hematology, including bone marrow aspiration, biopsy and interpretation, coagulation testing, blood banking, chemotherapy administration and stem cell transplantation. The Division is a member of the Southwest Oncology Group and is a site for numerous investigational drug and treatment trials in hematologic, as well as malignant disease.

- Prashanti Atluri, MD
Program Director, Oncology/Hematology Fellowship Program

Program at a Glance

Number of Fellowship Positions: 6

4th Year Medical Student Elective: Yes

Fellow Elective(s): Special Hematology, Blood Bank, Radiation Oncology, Stem Cell Transplant, Gynecologic Oncology, Research

  • Over the past five years, all fellowship graduates have obtained board certification in hematology and medical oncology
  • Access to a wide variety of pathology, including more than 2,400 new cancer diagnoses annually
  • Outpatient continuity experience maintained throughout the three years
  • Extensive didactic training including weekly hematology and oncology teaching conferences, Grand Rounds, and specialty tumor board meetings
  • Full range of clinical programs, including autologous stem cell transplantation program, SWOG clinical trials participation, a dedicated inpatient oncology unit and an outpatient chemotherapy/transfusion treatment suite.
  • Generous house staff benefits, including heavily subsidized housing and three complimentary meals per day

Curriculum

During the first two years of training, the fellowship program emphasize clinical training in Oncology and Hematology in six-month alternating blocks. Fellows perform consults daily on inpatient medical and surgical services, and have a major responsibility for the weekly outpatient Oncology/Hematology Teaching Practice. During the second year, fellows assume a leadership role in teaching and rounding on the inpatient services with Internal Medicine residents and first year fellows. During the third year, there is sustained scholarly activity, as well as continued outpatient experience. Third year fellows continue in a leadership role, overseeing junior fellows during continued outpatient experiences and have the opportunity to explore special interests via electives in Pediatric Oncology, Gynecologic Oncology, Tumor Pathology, Cytogenetics, and Molecular Methods. Fellows also dedicate time to scholarly and research activities/publishing. Teaching conferences in both specialties are provided throughout the three years of fellowship training.

Rotations in Months

  Rotation Months
PGY 4 Oncology 5.5
  Hematology 5.5
  Radiation Oncology 0.5
  Palliative Care 0.5
 
PGY 5 Oncology 5
  Hematology 4
  Blood Bank 1
  Cytogenetics 1
  Research 1
 
PGY 6 Research 2
  Gynecologic Oncology/Neuro-Oncology 1
  Breast Oncology 1
  Gastrointestinal Oncology 1
  Genitourinary Oncology 1
  Lung Oncology 1
  Malignant Hematology 1
  Bone Marrow Transplant 1
  Elective 3

Clinical Services

Seven full-time attending physicians, all double-boarded in Hematology and Medical Oncology

Full array of tertiary services to support complex treatment protocols including robotic surgery, infectious disease, rehabilitation, radiopharmaceuticals, advanced endoscopy, cyberknife radiosurgery, and genetics counseling. A new 32-chair state-of-the-art infusion center and a dedicated inpatient unit for ambulatory and inpatient treatments. Access to a wide variety of pathology, including more than 2000 cases annually, treatments including intensity modulated radiation therapy, monoclonal antibody based therapy, and autologous stem cell transplantation.

Research: We have a new generation of investigational trials using newer targeted agents. NYU Winthrop participates in numerous cancer clinical trials and faculty interests include epidemiology of colon cancer as well as tumor marker validation in breast and lung cancers.

Key Faculty

Prashanti Atluri, M.D.
Program Director, Oncology Hematology Fellowship
Associate Professor of Medicine

Jeffrey Schneider, M.D.
Chief, Oncology Hematology Division
Director, Thoracic Lung Cancer Program
Associate Professor of Medicine

Alexander Hindenburg, M.D.
Associate Professor of Medicine

Michael Garrison, M.D.
Assistant Professor of Medicine

Nina D’Abreo, M.D.
Assistant Professor of Medicine

Mary O’Keeffe, M.D.
Assistant Professor of Medicine